Indoco Remedies Complete Financial Statements
In FY2026, Indoco Remedies (INDOCO) reported revenue ₹460 Cr, net profit ₹-24 Cr and EPS ₹-2.57, with a net profit margin of -5.2% and ROE of -2.6%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review INDOCO earnings multiple to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
INDOCO Revenue, Net Profit & EBITDA — Year-on-Year Growth
INDOCO YoY (Mar 2025 vs Mar 2026) — revenue +19.2%, net profit +41.5%, EBITDA +780.0%, expenses +9.0%. Explore INDOCO value investing to estimate fundamental worth using multiple valuation models.
INDOCO Income Statement — Revenue, EBITDA & Net Profit
Indoco Remedies revenue ₹460 Cr, EBITDA ₹34 Cr, net profit ₹-24 Cr, EPS ₹-2.57 (2026) — net profit margin -5.2%. For live price, earnings ratios and company overview, see Indoco Remedies screener.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 460 | 473 | 386 | 433 | 435 | 432 | 462 | 425 | 404 | 478 | 429 | 417 | 461 | 405 | 401 | 396 | 412 | 374 | 297 | 382 | 349 | 324 | 264 | 267 | 334 | 287 | 250 | 248 | 284 | 237 | 213 | 249 |
| Expenses | 426 | 442 | 391 | 422 | 420 | 392 | 401 | 384 | 399 | 410 | 363 | 365 | 405 | 345 | 329 | 337 | 337 | 300 | 250 | 300 | 285 | 268 | 239 | 227 | 272 | 260 | 224 | 230 | 255 | 224 | 206 | 238 |
| EBITDA | 34 | 30 | -5 | 10 | 15 | 40 | 61 | 42 | 6 | 68 | 66 | 52 | 56 | 60 | 72 | 60 | 74 | 74 | 47 | 82 | 65 | 56 | 25 | 40 | 62 | 27 | 26 | 18 | 30 | 13 | 7 | 11 |
| Operating Profit Margin % | 7.00% | 6.00% | -2.00% | 2.00% | 3.00% | 9.00% | 9.00% | 10.00% | 1.00% | 13.00% | 15.00% | 12.00% | 12.00% | 15.00% | 18.00% | 15.00% | 18.00% | 19.00% | 15.00% | 21.00% | 18.00% | 17.00% | 9.00% | 15.00% | 18.00% | 9.00% | 9.00% | 7.00% | 10.00% | 5.00% | 3.00% | 4.00% |
| Depreciation | 33 | 32 | 29 | 30 | 32 | 29 | 26 | 28 | 29 | 21 | 18 | 20 | 24 | 16 | 18 | 20 | 17 | 20 | 19 | 22 | 19 | 19 | 18 | 19 | 17 | 18 | 20 | 17 | 18 | 18 | 17 | 18 |
| Interest | 46 | 25 | 18 | 26 | 26 | 18 | 12 | 14 | 16 | 8 | 9 | 8 | 10 | 5 | 3 | 4 | 7 | 3 | 5 | 4 | 4 | 6 | 8 | 6 | 6 | 5 | 5 | 6 | 7 | 5 | 7 | 4 |
| Profit Before Tax | -25 | -14 | -46 | -37 | -31 | -5 | 33 | 7 | -31 | 46 | 39 | 34 | 23 | 67 | 60 | 48 | 38 | 65 | 34 | 61 | 51 | 37 | 8 | 24 | 38 | 10 | 9 | 0 | 11 | -10 | -12 | 4 |
| Tax | -1 | -4 | -4 | 0 | -2 | 5 | 11 | 5 | -3 | 11 | 13 | 10 | 7 | 18 | 19 | 10 | 10 | 23 | 9 | 22 | 18 | 11 | 2 | 7 | 12 | 2 | -2 | -2 | 2 | -3 | 0 | -1 |
| Net Profit | -24 | -9 | -41 | -36 | -30 | -10 | 22 | 2 | -28 | 35 | 26 | 24 | 16 | 50 | 41 | 39 | 28 | 42 | 25 | 40 | 33 | 26 | 5 | 17 | 25 | 8 | 12 | 2 | 9 | -7 | -12 | 5 |
| Earnings Per Share (₹) | -2.57 | -1.00 | -4.48 | -3.94 | -3.20 | -1.09 | 2.39 | 0.20 | -3.08 | 3.82 | 2.80 | 2.62 | 1.69 | 5.40 | 4.39 | 4.19 | 3.05 | 4.52 | 2.71 | 4.30 | 3.58 | 2.78 | 0.58 | 1.85 | 2.75 | 0.85 | 1.25 | 0.20 | 0.99 | -0.81 | -1.32 | 0.57 |
INDOCO Balance Sheet — Assets, Liabilities & Shareholders' Equity
INDOCO total assets ₹2,593 Cr, total equity ₹939 Cr, total liabilities ₹ Cr (2026) — ROE -2.6%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 2,593 | 2,430 | 2,145 | 1,658 | 1,486 | 1,315 | 1,272 | 1,258 | 1,236 | 1,197 | 941 | 846 |
| Current Assets | 1,193 | 1,001 | 955 | 814 | 774 | 623 | 563 | 538 | 537 | 572 | 465 | 385 |
| Fixed Assets | 1,262 | 997 | 954 | 678 | 555 | 570 | 590 | 468 | 489 | 440 | 374 | 340 |
| Capital Work in Progress | 28 | 321 | 125 | 114 | 122 | 68 | 51 | 185 | 136 | 91 | 55 | 63 |
| Investments | 405 | 2 | 9 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 |
| Other Assets | 0 | 1,111 | 1,057 | 864 | 809 | 677 | 631 | 605 | 612 | 666 | 496 | 443 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 609 | 604 | 422 | 205 | 157 | 139 | 133 | 152 | 146 | 155 | 61 | 65 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 939 | 1,018 | 1,111 | 1,028 | 905 | 769 | 680 | 661 | 675 | 651 | 577 | 519 |
| Share Capital | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves & Surplus | 921 | 1,004 | 1,092 | 1,010 | 886 | 751 | 661 | 642 | 657 | 633 | 558 | 500 |
INDOCO Cash Flow Statement — Operating, Investing & Financing
Indoco Remedies operating cash flow ₹95 Cr, investing ₹-339 Cr, financing ₹241 Cr, net cash flow ₹-3 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 95 | 155 | 179 | 174 | 82 | 123 | 132 | 123 | 89 | 112 | 109 |
| Investing Activities | -339 | -432 | -208 | -121 | -67 | -56 | -104 | -135 | -171 | -111 | -88 |
| Financing Activities | 241 | 280 | 23 | -44 | -30 | -64 | -16 | -39 | 132 | -2 | -20 |
| Net Cash Flow | -3 | 4 | -7 | 8 | -14 | 3 | 12 | -52 | 50 | 0 | 1 |